Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Peripheral Blood Progenitor Cell Transplantation: Clinical, Practical, and Economic Considerations
1994
Automated Enumeration of CD34 + Cells in Peripheral Blood and Bone Marrow
1994
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.
1993
Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment
2002
Contribution of platelets to tumour metastasis
2011 Standout
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Neutrophils at work
2014 Standout
Advances in stem cell mobilization
2012
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Escalating drug delivery in cancer chemotherapy: A review of concepts and practice —Part 2
1993
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
1996 Standout
The human basophil
1990
Mobilization and collection of peripheral blood progenitor cells for transplantation
2005
Autologous hemopoietic stem cell transplantation. A possible cure for rheumatoid arthritis?
1997
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Recombinant protein expression in Escherichia coli: advances and challenges
2014 Standout
Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling
1989 Standout
Graft-versus-host disease
2009 Standout
Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential
2005 Standout
Human Interleukin‐3 inhibits the binding of granulocyte‐macrophage colony‐stimulating factor and interleukin‐5 to basophils and strongly enhances their functional activity
1990
Cytokines and hematopoietic stem cell mobilization
2006
A Comparative Review of Colony-Stimulating Factors
1997
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
A review of autologous hematopoietic cell transplantation
2000 Nobel
Diagnostic criteria and classification of mastocytosis: a consensus proposal
2001 Standout
Ex vivo characterization of human thymic dendritic cell subsets
2007 StandoutNobel
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
1999 Standout
Cancer of the Ovary
2004 Standout
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
1992
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.
1989
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients
1991
Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry
1991
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.
1989
The rate of telomere sequence loss in human leukocytes varies with age
1998 StandoutNobel
Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes
1990
Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils.
1991
The Absolute Number of Peripheral Blood CD34+ Cells Predicts a Timing for Apheresis and Progenitor Cell Yield in Patients with Hematologic Malignancies and Solid Tumors
2003 StandoutNobel
Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow
1991
Peripheral Blood Stem Cell Transplantations: Past, present and future
1993
Human Adipose Tissue Is a Source of Multipotent Stem Cells
2002 Standout
Growth Factors and Cancer
1991 StandoutScience
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation
1995
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Interleukin-5, eosinophils, and disease
1992 Standout
Functional Differences between Subpopulations of Mobilized Peripheral Blood‐Derived CD34+Cells Expressing Different Levels of HLA‐DR, CD33, CD38 and c‐kit Antigens
1997
New fusion protein systems designed to give soluble expression in Escherichia coli.
1999
Synthesis of Proteins by Native Chemical Ligation
1994 StandoutScience
The Platelet Count in Carcinoma of the Lung and Colon
1990
Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist
1996
Signal transduction of the human granulocyte-macrophage colony- stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins
1990
Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding.
1992
A mutation of the common receptor subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor, and IL-5 that leads to ligand independence and tumorigenicity
1994
Differentiation and proliferation of hematopoietic stem cells
1993
Works of To Lb being referenced
The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia.
1989
CFU-mix are no better than CFU-GM in predicting hemopoietic reconstitutive capacity of peripheral blood stem cells collected in the very early remission phase of acute nonlymphoblastic leukemia.
1987
Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia.
1988
Autologous blood stem cell transplantation.
1989
Autotransplantation using peripheral blood stem cells mobilized by cyclophosphamide.
1989
Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness with differentiation in the neutrophilic myeloid series
1988
Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies.
1994
An unusual pattern of hemopoietic reconstitution in patients with acute myeloid leukemia transplanted with autologous recovery phase peripheral blood.
1990